Literature DB >> 20467764

Impact of psychostimulants and atomoxetine on the expression of 8-hydroxyguanine glycosylase 1 in human cells.

Andreas Johannes Schmidt1, Hans-Willi Clement, Stefan Gebhardt, Ulrich Michael Hemmeter, Eberhard Schulz, Jürgen-Christian Krieg, Tilo Kircher, Philip Heiser.   

Abstract

Oxidative DNA damage as one sign of reactive oxygen species induced oxidative stress is an important factor in the pathogenesis of various psychiatric disorders. Altered levels of DNA base damage products as well as the expression of the main repair enzyme 8-hydroxyguanine glycosylase 1 have been described. The aim of the present study was to examine the effects of drugs (amphetamine, methylphenidate and atomoxetine) used in the treatment of attention deficit-hyperactivity disorder on the expression of this enzyme via reverse transcriptase-polymerase chain reaction in human neuroblastoma SH-SY5Y and human monocytic U-937 cells at concentrations of 50, 500 and 5,000 ng/ml. We observed decreased expression of this enzyme for all applied substances. In U-937 cells, the significance level was reached after treatment with 5,000 ng/ml amphetamine as well as after treatment with 50, 500 and 5,000 ng/ml atomoxetine. Incubation of SH-SY5Y cells with 50 and 5,000 ng/ml amphetamine and 5,000 ng/ml methylphenidate led to significant decreases of 8-hydroxyguanine glycosylase 1. As a positive correlation between the expression of 8-hydroxyguanine glycosylase 1 and the level of oxidative DNA damage products has been described, we accordingly consider these substances (amphetamine, methylphenidate and atomoxetine) to possibly play a protective role in this process.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20467764     DOI: 10.1007/s00702-010-0408-5

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  24 in total

1.  Effects of different antipsychotics and the antidepressant mirtazapine on glucose transporter mRNA levels in human blood cells.

Authors:  P Heiser; S Singh; J C Krieg; H Vedder
Journal:  J Psychiatr Res       Date:  2005-07-05       Impact factor: 4.791

2.  Depression and possible cancer risk due to oxidative DNA damage.

Authors:  Masahiro Irie; Masakazu Miyata; Hiroshi Kasai
Journal:  J Psychiatr Res       Date:  2005-04-26       Impact factor: 4.791

3.  Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease.

Authors:  J Wang; S Xiong; C Xie; W R Markesbery; M A Lovell
Journal:  J Neurochem       Date:  2005-05       Impact factor: 5.372

4.  Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients.

Authors:  L Migliore; I Fontana; F Trippi; R Colognato; F Coppedè; G Tognoni; B Nucciarone; G Siciliano
Journal:  Neurobiol Aging       Date:  2005-05       Impact factor: 4.673

5.  Impact of drugs approved for treating ADHD on the cell survival and energy metabolism: an in-vitro study in human neuronal and immune cells.

Authors:  A J Schmidt; J C Krieg; H W Clement; S Gebhardt; E Schulz; P Heiser
Journal:  J Psychopharmacol       Date:  2009-07-15       Impact factor: 4.153

Review 6.  Oxidative DNA damage: assessment of the role in carcinogenesis, atherosclerosis, and acquired immunodeficiency syndrome.

Authors:  Ryszard Olinski; Daniel Gackowski; Marek Foksinski; Rafal Rozalski; Krzysztof Roszkowski; Pawel Jaruga
Journal:  Free Radic Biol Med       Date:  2002-07-15       Impact factor: 7.376

7.  Oxidative DNA damage in peripheral leukocytes and its association with expression and polymorphisms of hOGG1: a study of adolescents in a high risk region for hepatocellular carcinoma in China.

Authors:  Tao Peng; Han-Ming Shen; Zhi-Ming Liu; Lu-Nan Yan; Min-Hao Peng; Le-Qun Li; Ren-Xiang Liang; Zong-Liang Wei; Barry Halliwell; Choon Nam Ong
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

8.  Evidence for oxidative DNA damage in the hippocampus of elderly patients with chronic schizophrenia.

Authors:  Naoya Nishioka; Steven E Arnold
Journal:  Am J Geriatr Psychiatry       Date:  2004 Mar-Apr       Impact factor: 4.105

9.  Oxidative imbalance in adult attention deficit/hyperactivity disorder.

Authors:  Salih Selek; Haluk A Savas; H Serdar Gergerlioglu; Mahmut Bulut; H Ramazan Yilmaz
Journal:  Biol Psychol       Date:  2008-07-03       Impact factor: 3.251

10.  Does methylphenidate cause a cytogenetic effect in children with attention deficit hyperactivity disorder?

Authors:  Susanne Walitza; Birgit Werner; Marcel Romanos; Andreas Warnke; Manfred Gerlach; Helga Stopper
Journal:  Environ Health Perspect       Date:  2007-02-21       Impact factor: 9.031

View more
  3 in total

Review 1.  In vitro study methodologies to investigate genetic aspects and effects of drugs used in attention-deficit hyperactivity disorder.

Authors:  Edna Grünblatt; Jasmin Bartl; Zoya Marinova; Susanne Walitza
Journal:  J Neural Transm (Vienna)       Date:  2012-07-26       Impact factor: 3.575

2.  Using Cell Cultures for the Investigation of Treatments for Attention Deficit Hyperactivity Disorder: A Systematic Review.

Authors:  Danielly Chierrito; Camila B Villas-Boas; Fernanda S Tonin; Fernando Fernandez-Llimos; Andréia C C Sanches; João C P de Mello
Journal:  Curr Neuropharmacol       Date:  2019       Impact factor: 7.363

3.  A Pilot Study on the Association of Lead, 8-Hydroxyguanine, and Malondialdehyde Levels in Opium Addicts' Blood Serum with Illicit Drug Use and Non-Addict Persons.

Authors:  Farzaneh Allahdinian Hesaruiyeh; Saeed Rajabi; Mohadeseh Motamed-Jahromi; Mohammad Sarhadi; Michelle L Bell; Razieh Khaksefidi; Somayeh Sarhadi; Leili Mohammadi; Kamal Dua; Amin Mohammadpour; Paolo Martelletti
Journal:  Int J Environ Res Public Health       Date:  2022-07-26       Impact factor: 4.614

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.